Biallelic KCTD7 mutations define the diagnosis of EPM3 (progressive myoclonic epilepsy-3), a severe neurodegenerative disorder with onset in early childhood [4, 76]. Here, KCTD7 is linked to Progressive myoclonic epilepsy.